机构

• 上海药物研究所 [15]
• 合肥物质科学研究院 [15]
• 自动化研究所 [4]
• 地质与地球物理研究所 [1]
• 计算技术研究所 [1]
• 数学与系统科学研究院 [1]
• 更多

采集方式

• OAI收割 [38]
• iSwitch采集 [1]

内容类型

• 期刊论文 [39]

发表日期

• 2025 [2]
• 2024 [5]
• 2023 [2]
• 2022 [12]
• 2021 [8]
• 2020 [5]
• 更多

学科主题

筛选

浏览/检索结果: 共39条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序作者升序作者降序 De Novo Design of Structure-Tunable Multivalent Targeting Chimeras for Tumor-Targeted PD-L1 Degradation and Potentiated Cancer Immunotherapy 期刊论文  OAI收割 ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 页码: 17 作者:  Zhou, Huiling;  Hou, Bo;  Shan, Yiming;  Huang, Lujia;  Chen, Fangmin   |  收藏  |  浏览/下载：1/0  |  提交时间：2025/06/23 Combinatory therapy, Immune checkpoint blockade, Multivalent targeting chimeras  Tumor microenvironment  Tumor-specific PD-L1 degradation   Geriatric Nutritional Risk Index is an effective prognostic predictor for metastatic/recurrent or unresectable esophageal cancer receiving immunotherapy 期刊论文  OAI收割 JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 卷号: 16, 期号: 1, 页码: 22 作者:  Wang, Bei;  Wang, Zixuan;  Xu, Chuanhai;  Wang, Yueqin;  Gao, Honglan   |  收藏  |  浏览/下载：1/0  |  提交时间：2025/05/27 Geriatric Nutritional Risk Index (GNRI)  esophageal squamous cell carcinoma (ESCC)  immune checkpoint inhibitors (ICIs)  programmed cell death ligand 1 (PD-L1)   Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials 期刊论文  OAI收割 SCIENCE CHINA-LIFE SCIENCES, 2024 作者:  Wang, Jinliang;  Zhou, Wenyong;  Xu, Yu;  Duan, Jianchun;  Zhou, Qiaoxia   |  收藏  |  浏览/下载：7/0  |  提交时间：2024/11/20 non-squamous NSCLC  squamous NSCLC  LRP1B deleterious mutations  predictive biomarker  immune checkpoint inhibitor   Enhancing immunotherapy efficacy against MHC-I deficient triple-negative breast cancer using LCL161-loaded macrophage membrane-decorated nanoparticles 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2024, 卷号: 14, 期号: 7, 页码: 3218-3231 作者:  Zhang, Wen;  Zhai, Yihui;  Cai, Ying;  Gong, Xiang;  Jiang, Yunxuan   |  收藏  |  浏览/下载：15/0  |  提交时间：2024/08/22 MHC-I deficiency  Macrophage  CD47  Immunotherapy  Triple-negative breast cancer  Phagocytosis  Immune checkpoint  Innate immunity   Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/ mismatch repair-deficient solid tumors 期刊论文  OAI收割 CHINESE JOURNAL OF CANCER RESEARCH, 2024, 卷号: 36 作者:  Li, Jian;  Xu, Ye;  Zang, Aimin;  Gao, Yunong;  Gao, Quanli   |  收藏  |  浏览/下载：14/0  |  提交时间：2024/11/22 Biomarkers  DNA mismatch repair  immune checkpoint inhibitors  microsatellite instability  phase II clinical trials  programmed cell death 1 receptor   Low-Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells 期刊论文  OAI收割 ADVANCED SCIENCE, 2024, 页码: 17 作者:  Pu, Congying;  Li, Yize;  Fu, Yixian;  Yan, Yiyang;  Tao, Siyao   |  收藏  |  浏览/下载：49/0  |  提交时间：2024/02/27 AIM2 inflammasome  chemotherapy  gut microbiome  ileal epithelial cells  immune checkpoint blockade  lactobacillus  segmented filamentous bacterium   The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy 期刊论文  OAI收割 THERANOSTICS, 2024, 卷号: 14, 期号: 3, 页码: 1195-1211 作者:  Zhang, Ying;  Akhil, Venu;  Seo, Ho Seong;  Park, Hae Ran;  Kim, Soo Hyun   |  收藏  |  浏览/下载：23/0  |  提交时间：2024/05/07 Cancer radiotherapy  immunogenic cell death  calreticulin  L-ASNase  reactive oxygen species  immune checkpoint inhibitor   Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4748-4764 作者:  Liu, Yingqiang;  Zhan, Zhengsheng;  Kang, Zhuang;  Li, Mengyuan;  Lv, Yongcong   |  收藏  |  浏览/下载：31/0  |  提交时间：2024/01/26 Small molecule inhibitor  Tumor microenvironment  Immune-checkpoint  immune-deficient mouse models  including temozolomide (TMZ) insensitive tumors. Notably   Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer 期刊论文  OAI收割 JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 12, 页码: 2315-2328 作者:  Luo, LingJie   |  收藏  |  浏览/下载：29/0  |  提交时间：2023/10/17 Immune checkpoint inhibitor  Phytochemicals  Combination therapy  Immune-related adverse events  Predictive biomarker  Gut microbiota   Biogenic platinum nanoparticles on bacterial fragments for enhanced radiotherapy to boost antitumor immunity 期刊论文  OAI收割 NANO TODAY, 2022, 卷号: 47, 页码: 10 作者:  Deng, Zheng;  Liu, Jiawei;  Xi, Min;  Wang, Chunjie;  Fang, Huapan   |  收藏  |  浏览/下载：13/0  |  提交时间：2023/12/29 Radiotherapy  Platinum nanoparticles  Shewanella oneidensis MR-1  Immune checkpoint blockade  Anti-tumor immunity